Literature DB >> 25713383

Differential fates of biomolecules delivered to target cells via extracellular vesicles.

Masamitsu Kanada1, Michael H Bachmann1, Jonathan W Hardy1, Daniel Omar Frimannson2, Laura Bronsart1, Andrew Wang1, Matthew D Sylvester2, Tobi L Schmidt1, Roger L Kaspar3, Manish J Butte1, A C Matin2, Christopher H Contag4.   

Abstract

Extracellular vesicles (EVs), specifically exosomes and microvesicles (MVs), are presumed to play key roles in cell-cell communication via transfer of biomolecules between cells. The biogenesis of these two types of EVs differs as they originate from either the endosomal (exosomes) or plasma (MVs) membranes. To elucidate the primary means through which EVs mediate intercellular communication, we characterized their ability to encapsulate and deliver different types of macromolecules from transiently transfected cells. Both EV types encapsulated reporter proteins and mRNA but only MVs transferred the reporter function to recipient cells. De novo reporter protein expression in recipient cells resulted only from plasmid DNA (pDNA) after delivery via MVs. Reporter mRNA was delivered to recipient cells by both EV types, but was rapidly degraded without being translated. MVs also mediated delivery of functional pDNA encoding Cre recombinase in vivo to tissues in transgenic Cre-lox reporter mice. Within the parameters of this study, MVs delivered functional pDNA, but not RNA, whereas exosomes from the same source did not deliver functional nucleic acids. These results have significant implications for understanding the role of EVs in cellular communication and for development of EVs as delivery tools. Moreover, studies using EVs from transiently transfected cells may be confounded by a predominance of pDNA transfer.

Entities:  

Keywords:  apoptotic body; cell communication; exosome; extracellular vesicle; microvesicle

Mesh:

Substances:

Year:  2015        PMID: 25713383      PMCID: PMC4378439          DOI: 10.1073/pnas.1418401112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  74 in total

1.  Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.

Authors:  B Y Yung; A M Bor; P K Chan
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

2.  Designed guanidinium-rich amphipathic oligocarbonate molecular transporters complex, deliver and release siRNA in cells.

Authors:  Erika I Geihe; Christina B Cooley; Jeff R Simon; Matthew K Kiesewetter; Justin A Edward; Robyn P Hickerson; Roger L Kaspar; James L Hedrick; Robert M Waymouth; Paul A Wender
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

3.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules.

Authors:  H F Heijnen; A E Schiel; R Fijnheer; H J Geuze; J J Sixma
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

4.  Secreted monocytic miR-150 enhances targeted endothelial cell migration.

Authors:  Yujing Zhang; Danqing Liu; Xi Chen; Jing Li; Limin Li; Zhen Bian; Fei Sun; Jiuwei Lu; Yuan Yin; Xing Cai; Qi Sun; Kehui Wang; Yi Ba; Qiang Wang; Dongjin Wang; Junwei Yang; Pingsheng Liu; Tao Xu; Qiao Yan; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

5.  Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis.

Authors:  Weiying Zhou; Miranda Y Fong; Yongfen Min; George Somlo; Liang Liu; Melanie R Palomares; Yang Yu; Amy Chow; Sean Timothy Francis O'Connor; Andrew R Chin; Yun Yen; Yafan Wang; Eric G Marcusson; Peiguo Chu; Jun Wu; Xiwei Wu; Arthur Xuejun Li; Zhuo Li; Hanlin Gao; Xiubao Ren; Mark P Boldin; Pengnian Charles Lin; Shizhen Emily Wang
Journal:  Cancer Cell       Date:  2014-04-14       Impact factor: 31.743

6.  Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration.

Authors:  Valbona Luga; Liang Zhang; Alicia M Viloria-Petit; Abiodun A Ogunjimi; Mohammad R Inanlou; Elaine Chiu; Marguerite Buchanan; Abdel Nasser Hosein; Mark Basik; Jeffrey L Wrana
Journal:  Cell       Date:  2012-12-21       Impact factor: 41.582

7.  Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection.

Authors:  Yuki Takahashi; Makiya Nishikawa; Haruka Shinotsuka; Yuriko Matsui; Saori Ohara; Takafumi Imai; Yoshinobu Takakura
Journal:  J Biotechnol       Date:  2013-04-02       Impact factor: 3.307

8.  Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes.

Authors:  Jessica Wahlgren; Tanya De L Karlson; Mikael Brisslert; Forugh Vaziri Sani; Esbjörn Telemo; Per Sunnerhagen; Hadi Valadi
Journal:  Nucleic Acids Res       Date:  2012-05-22       Impact factor: 16.971

9.  Characterization of RNA in exosomes secreted by human breast cancer cell lines using next-generation sequencing.

Authors:  Piroon Jenjaroenpun; Yuliya Kremenska; Vrundha M Nair; Maksym Kremenskoy; Baby Joseph; Igor V Kurochkin
Journal:  PeerJ       Date:  2013-11-05       Impact factor: 2.984

10.  Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth.

Authors:  Arda Mizrak; Mehmet Fatih Bolukbasi; Gokhan Baris Ozdener; Gary J Brenner; Sibylle Madlener; Erdogan Pekcan Erkan; Thomas Ströbel; Xandra O Breakefield; Okay Saydam
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454

View more
  154 in total

Review 1.  Exosomes or microvesicles? Two kinds of extracellular vesicles with different routes to modify protozoan-host cell interaction.

Authors:  Ingrid Evans-Osses; Luis H Reichembach; Marcel I Ramirez
Journal:  Parasitol Res       Date:  2015-08-15       Impact factor: 2.289

2.  Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes.

Authors:  Joanna Kowal; Guillaume Arras; Marina Colombo; Mabel Jouve; Jakob Paul Morath; Bjarke Primdal-Bengtson; Florent Dingli; Damarys Loew; Mercedes Tkach; Clotilde Théry
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 3.  Tumor-derived extracellular vesicles: molecular parcels that enable regulation of the immune response in cancer.

Authors:  Colin Sheehan; Crislyn D'Souza-Schorey
Journal:  J Cell Sci       Date:  2019-10-15       Impact factor: 5.285

4.  Modulation of cellular function through immune-activated exosomes.

Authors:  Lynn Pulliam; Archana Gupta
Journal:  DNA Cell Biol       Date:  2015-05-06       Impact factor: 3.311

5.  Emerging picture of the distinct traits and functions of microvesicles and exosomes.

Authors:  Marc A Antonyak; Richard A Cerione
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-11       Impact factor: 11.205

Review 6.  Exosomes: cell-created drug delivery systems.

Authors:  Anastasia Familtseva; Nevena Jeremic; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2019-05-09       Impact factor: 3.396

Review 7.  Extracellular vesicle docking at the cellular port: Extracellular vesicle binding and uptake.

Authors:  Kinsley C French; Marc A Antonyak; Richard A Cerione
Journal:  Semin Cell Dev Biol       Date:  2017-01-16       Impact factor: 7.727

Review 8.  Going live with tumor exosomes and microvesicles.

Authors:  Vincent Hyenne; Olivier Lefebvre; Jacky G Goetz
Journal:  Cell Adh Migr       Date:  2017-01-31       Impact factor: 3.405

Review 9.  Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.

Authors:  James P K Armstrong; Margaret N Holme; Molly M Stevens
Journal:  ACS Nano       Date:  2017-01-09       Impact factor: 15.881

Review 10.  Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson's Disease, Glioma, and Schwannoma.

Authors:  Justin Hall; Shilpa Prabhakar; Leonora Balaj; Charles P Lai; Richard A Cerione; Xandra O Breakefield
Journal:  Cell Mol Neurobiol       Date:  2016-03-26       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.